TM4SF1 Upregulates MYH9 to Activate the NOTCH Pathway to Promote Cancer Stemness and Lenvatinib Resistance in HCC

Researchers found through abundant in vitro and in vivo> experiments which the expression of TM4SF1 was positively correlated with the progression and cancer stemness of hepatocellular carcinoma (HCC).